Stock Market Today: Dow DJI Drops 513, Nasdaq IXIC Up, S&P 500 SPX Eyes 7,500 as ANT Debuts
A 5.08% 10-year caps the S&P 500 at 7,306; reclaiming 7,400 opens 7,500 | That’s TradingNEWS
Key Points
- Anthropic priced 980 million shares at $83, raising a record $81.34B, with ANT indicated at $105–$110 pre-trade.
- UnitedHealth fell another 5%, taking its five-day slide to 18% and dragging the Dow below 50,000.
- AMD dropped as much as 11% to $484 after a short report flagged $7.75B in China and Hong Kong revenue.
The split that defined Wednesday’s close got wider on Thursday morning. By 11:31 a.m. ET the Dow Jones Industrial Average was down 513.32 points, or 1.02%, at 49,684.85. It had closed Wednesday at 50,198.17, its lowest finish since June, and today it slipped back under the 50,000 line that held through the first five weeks of the quarter. The Nasdaq Composite was up 65.25 points, or 0.27%, at 24,495.14. The S&P 500 was down 17.43 points, or 0.24%, at 7,306.20, putting the index on track for a sixth straight losing session after Wednesday’s 7,323.63 close completed its longest losing run since June. The Russell 2000 was down 21.05 points, or 0.78%, at 2,693.26, so small caps were underperforming the large-cap tape for a second day.
That spread, a Nasdaq in the green against a Dow down more than 500 points, is not a sign of strength. Both sides of the market are being driven by a handful of names. The Nasdaq is being held up by a burst of AI enthusiasm tied to Anthropic’s first trading day. The Dow is being pulled down by a healthcare liquidation that has not stopped since the Centers for Medicare & Medicaid Services proposed its anti-fraud rule on November 16, plus a short-seller attack on AMD that hit just as the opening rally peaked. When one index climbs 2% at the open and gives most of it back within 90 minutes while the price-weighted Dow drops more than 700 points from its high, the buying was narrow and the selling is broad.
The volatility gauge says the same thing. The VIX was up 0.93 points, or 3.79%, at 25.49 late in the morning. Earlier, while the opening rally still held, it had fallen 6.7% to 22.91. A move back toward 25.5 means traders are paying more for protection even with an AI-positive headline on the screen. The 10-year Treasury yield sat between 5.07% and 5.085% all morning, keeping the discount rate on long-duration equities at its highest level in more than a decade. Gold fell $58.80, or 1.57%, to $3,683.10, and December WTI crude rose $1.12, or 1.36%, to $83.43.
The read at the midpoint of the session is clear. One historic listing has not reversed a five-day drawdown, and the market’s first real test of the Anthropic effect is going badly outside the Nasdaq. A broadly positive day needs the Dow back above 50,000 and the S&P 500 back over its 7,323.63 prior close, and neither had happened by late morning.
From a 2% Futures Gap to a Late-Morning Fade: How the Session Unwound
Thursday started with the strongest overnight bid in weeks. Before the open, Nasdaq 100 futures were up 1.9%, S&P 500 futures were up 1.1% and Dow futures were up 0.7% as traders reacted to Anthropic pricing its IPO above the marketed range. At 8:02 a.m. ET, QQQ, the Nasdaq 100 tracking fund, was up 2.06% and SPY, the S&P 500 fund, was up 1.22%. Semiconductors led the premarket move. Nvidia was up 1.5%, AMD 2.9%, Micron 4.8% and SK Hynix’s American depositary receipts 5.3% by 7:36 a.m. ET. Intel, Marvell, Lam Research and Applied Materials each added more than 4% before the bell.
The 8:30 a.m. data did not help. Initial jobless claims came in at 203,000, above the 197,000 consensus, and the Philadelphia Fed manufacturing index fell to 6.3 against an expected 23.2. Neither report stopped the opening bid. At the bell the S&P 500 rose more than 1%, and at the peak it was up 1.3%, putting it above 7,415. The Nasdaq reached a 2.1% gain, briefly trading above 24,940. The Dow was up more than 200 points, or 0.5%, in the first minutes. Dario and Daniela Amodei rang the Nasdaq opening bell, and indications for Anthropic’s first trade kept rising through the first hour.
The reversal started around 10 a.m. ET, as soon as the market had to decide whether the AI rally deserved follow-through. QQQ was up 2.06% at 10:04 a.m. ET and only 0.41% by 11:05 a.m. ET, a giveback of more than 80% of the opening gain in an hour. By midmorning the S&P 500 was up just 3.71 points at 7,327.34, the Dow was down 272.01 points at 49,926.16 and the Nasdaq’s gain had shrunk to 0.53% at 24,559.61. The next leg lower came from two places at once. AMD fell hard on a short report questioning its China exposure, and UnitedHealth extended its slide, which pulled the price-weighted Dow down further. Stocks then hit session lows, and technology was the only major group still in positive territory.
The pattern repeats what happened on Wednesday. Nvidia opened that session with a 4% premarket gain after its earnings beat and closed down 2.9%. Thursday’s opening gap on the Anthropic news has followed the same path. When strong news gets sold twice in two days, buyers are using the strength to cut exposure rather than add to it.
Anthropic’s $83 Pricing and the Record $81.34 Billion Raise
The event the market was waiting for is the largest IPO on record. Anthropic, PBC priced its Class A common stock at $83.00 per share, above the $70 to $78 range it had marketed, and set Nasdaq Global Select Market trading under the symbol ANT for November 19, with the offering closing November 20. The deal grew to 980 million Class A shares: 956,351,354 sold by the company and 23,648,646 by selling stockholders. At $83 the raise comes to $81.34 billion, ahead of the $75 billion SpaceX raised in June, and values the company at $1.5 trillion on a fully diluted basis.
Demand outran supply at every stage. The initial marketing range was built on 825 million shares, with up to 20% set aside for retail investors. Pricing $5 above the top of the range while also increasing the share count shows how deep the institutional book was, and retail demand was the largest ever recorded for a U.S. listing. UK retail buyers paid £63.20 a share, and $300 million of stock went to that channel.
The first trade had not printed by late morning. Nasdaq made the shares eligible to trade from 10:00 a.m. ET, and the price comes out of the opening auction run by the lead bank, which for an offering this size can finish hours after the 9:30 a.m. bell. At 10:10 a.m. ET the auction showed a bid and ask of $104.00, 25% above the IPO price. Indications then moved to $105, a 27% premium, then $108, and then $110, a 33% premium. At $110 the fully diluted value would sit near $2 trillion, which would put Anthropic above all but a few of the largest companies in the S&P 500 on its first day.
The pricing matters for the whole tape because it is the most direct read on how much the market will pay for AI exposure right now. The overnight futures move priced in a strong debut before a single share changed hands. The fade since 10 a.m. shows the market is paying for Anthropic itself and selling the chipmakers and infrastructure suppliers that had been the main AI trade for three years. Whatever the first print is, the money flowing into ANT has to come from somewhere, and part of it is coming out of the semiconductor stocks that opened higher.
What a $1.5 Trillion Valuation Asks of Anthropic’s Numbers
The IPO filing gives the market its first audited view of the business, and the growth rate explains why investors paid above the range. Sales for the nine months ended September 30, 2026 topped $33 billion. Revenue was $2.5 billion for all of 2025 and $41 million in 2023. The operating loss for the first nine months of 2026 narrowed to $1.3 billion from $5.2 billion a year earlier, a $3.9 billion improvement while revenue grew more than tenfold. Losses are shrinking as fast as sales are rising, and that is the operating leverage that justifies a premium multiple.
The multiple is still steep. If the nine-month figure is run at its exit pace, it implies an annualized revenue base in the mid-$40 billion range, which makes $1.5 trillion a multiple above 30 times sales before any first-day pop. An open at $110 would push it well above 40 times. The comparison set is short: no company has ever listed at this size with this growth rate, and the closest precedent, SpaceX in June, is now trading at a market cap of $1.919 trillion. The S-1 filed publicly on October 26 named the exchange and the ticker, and the roadshow finished in under four weeks.
There are caution signals. Of the 15 larger U.S. IPOs tracked this year, 12 trade below their offering price, so the post-listing record for 2026 mega-deals is poor once the first-day excitement passes. Earlier quarterly disclosures showed how much the stock market depends on Anthropic’s growth curve. In October, when the company reported third-quarter sales of $16.8 billion with sequential growth slowing from the 145% pace of the second quarter, chip stocks sold off. Intel fell 2.8%, Nvidia 1.8% and AMD 1.5% that day. Anthropic’s revenue line now works as a direct read on AI infrastructure spending, and it will be scrutinized every quarter.
The capital structure gives the company room. A raise above $80 billion funds compute commitments for several years without new equity, and management used the roadshow to discuss its debt and its effort to win an investment-grade credit rating. Seven co-founders sold shares worth close to $2 billion in the deal, a small slice of their holdings but a figure that will be cited every time the stock dips. For the broad index, the more important point is that the S&P 500’s biggest AI weights now share investor attention with a $1.5 trillion new entrant that has its own direct growth story.
Nvidia’s Five-Day Losing Streak and a Leadership Vacuum
Nvidia’s bounce is the clearest example of a beat-and-sell market. The stock closed Wednesday at $150.96, a 16-month low, after a 2.9% drop that erased the post-earnings gains. That finished a five-session losing streak and left the shares 36% below their October 6 record close. On Thursday the stock was up 1.5% to 1.8% in late morning trading, around $153, after reaching $153.83 premarket. It was green, but the bounce fell short of the 4% premarket gain it posted and then lost on Wednesday.
The fundamentals don’t explain the price. Fiscal third-quarter revenue more than doubled to $115.84 billion, against a $108.93 billion consensus. Earnings were $2.68 per share versus a $2.47 consensus, and guidance went up. On those numbers Nvidia trades near 12 times forward earnings, a multiple usually reserved for slow-growth industrial companies. Over seven straight beats the average one-day move after earnings has been a 2.97% decline, and this report followed that pattern.
The discount is about leadership. Founder Jensen Huang resigned as CEO on November 12, after more than three decades running the company, following disclosure of personal conduct the board deemed inconsistent with its code. CFO Colette Kress is interim CEO while the board runs an external search. During the earnings call, board chair Harvey Jones said the board accepted the resignation unanimously and does not intend to reinstate Huang, closing off any idea that the founder could return. On the day of the resignation the stock fell as much as 13% intraday before dip buyers cut the loss to 4%, and it has fallen 27% over the past month. At least ten Buy-to-Hold downgrades have arrived since the resignation, and one cut its target to $170 from $365.
The index effect is large because Nvidia remains one of the biggest weights in both the S&P 500 and the Nasdaq 100. A 36% drawdown in that position accounts for a big part of the S&P 500’s 4.1% decline over the past month. The board’s refusal to bring Huang back leaves a CEO search with no defined timeline, and until a permanent leader is named, Nvidia trades at a multiple with no premium for its founder’s track record. Thursday’s 1.5% bounce does not change that.
AMD Sinks as a Short Seller Targets Its China Exposure
The heaviest single-stock hit on the Nasdaq side came from AMD, which went from a 2.9% premarket gain to one of the session’s worst large-cap performers. The stock fell as much as 11% Thursday morning and traded at $484 after an 8% decline, when an investigative short seller disclosed a short position along with a report on the chipmaker’s links to Chinese entities on U.S. export blacklists. The fall came right as the opening rally peaked, and it was one of the two main forces that pushed the indices to session lows.
The report’s central claim concerns firmware. It says IEIT Systems, a Chinese server maker blacklisted by Washington in March 2025, kept publishing BIOS updates with newer AMD firmware after the blacklisting. It says nearly identical firmware turned up at Aivres, Kaytus and Maginfra, companies with reported ties to IEIT across China, Singapore and the U.S. The report itself states that no export-control violation has been established and that it could not determine how IEIT got the firmware or whether licenses existed. The selling went ahead anyway, because the stock is being priced on regulatory risk and not on legal findings.
The exposure behind the concern comes from AMD’s own filings. The company booked $7.75 billion of 2025 revenue in China and Hong Kong and billed another $4.28 billion to Singapore. Over 20% of total revenue goes to customers in China and Hong Kong. Two ventures that are 85% owned by Tongfu Microelectronics handle most of AMD’s chip assembly, testing and packaging. AMD owns the other 15% and lent one of the ventures $100 million, a loan still outstanding at the end of September. The report also flagged financial obligations of up to 320 million shares, valued at $161.1 billion at a recent close. A January 10 deadline that could widen the U.S. blacklist puts a date on the risk.
The timing makes the damage worse. Thursday’s Trump–Xi meetings ended with little change on semiconductors, rare earths or tariffs, so there was no policy relief to offset the report. Nvidia’s China sales have already gone to zero under current restrictions. Investors who had moved into AMD as the cleaner AI alternative now have a reason to price the same China discount into the second-largest GPU supplier. With Nvidia down 36% from its peak and AMD dropping double digits intraday, the two main AI accelerator stocks are both trading on governance and regulatory risk in the same week, even as AI capital spending keeps rising.
Memory, Storage and Chip Equipment Rip, Then the Bid Fades
The broader semiconductor and hardware group delivered Thursday’s biggest opening move and most of its giveback. Data-storage names rallied first. Seagate Technology was up more than 6% before the bell and Western Digital was up 5.8%, as traders bought the physical infrastructure behind model training and inference. Memory followed: Micron was up 4.8% in early trading and SK Hynix’s ADRs were up 5.3%. Equipment and networking joined in, with Intel, Marvell, Lam Research and Applied Materials each up more than 4% before the open.
Electronic design software got its own lift. Synopsys rose 3.2% after a fresh coverage initiation carried a $640 target, 47% above Wednesday’s close, on the view that semiconductor R&D spending will keep the EDA market growing. Mega-cap platform stocks split. Microsoft was up 2.3% in midmorning trade, Apple was down 1%, and Amazon and Alphabet, both large Anthropic shareholders, rose before the bell as proxies for the IPO’s value. Neocloud operators, the GPU-rental providers that have become the highest-beta part of AI infrastructure, were up more than 5% premarket.
The fade then hit these names hardest, because they had the most stretched positioning. When QQQ went from a 2.06% gain to 0.41% between 10:04 a.m. and 11:05 a.m. ET, the chip complex supplied most of that giveback. The AMD short report hit during the same window and spread to the whole accelerator supply chain, from packaging to memory. Nvidia held a 1.5% gain only because it started the day at a 16-month low with sellers already exhausted.
The setup has a history. Over the past six months this group has had several synchronized sell-offs set off by AI-lab headlines. In July, reports that Anthropic was exploring its own chips sent the Philadelphia Semiconductor Index down 4.3% in one session. In October, Anthropic’s slower third-quarter growth hit the chipmakers again. On another day, Sandisk fell 12.63%, Seagate 10%, Western Digital 9.15%, Intel 5.84% and Micron 5.65%. The market has learned to treat Anthropic news as an AI-supplier catalyst in either direction, and Thursday’s open-then-fade shows traders using a positive Anthropic headline to sell into strength.
Palo Alto Networks Rips on a Guidance Raise and a $4.5 Billion Deal
Cybersecurity was the one AI-adjacent group that kept most of its gains, and Palo Alto Networks led it. The shares rose 9.87% to $373.45 in premarket trading after the company raised its full-year outlook and announced a $4.5 billion deal for AI startup Applied Compute. The guidance change was large. Palo Alto now expects fiscal 2027 revenue of $14.52 billion to $14.57 billion, up from $14.10 billion to $14.20 billion before. At the midpoint that is a $395 million increase, or 2.8%, a big revision for a company this size this early in its fiscal year.
The deal is structured to protect the balance sheet. Palo Alto will pay for Applied Compute entirely in its own stock, using a share price that has just jumped to fund the acquisition and keeping its cash for buybacks and integration. The company has used its platform strategy, buying point products and folding them into one security stack, to justify a premium multiple, and adding an AI-native startup lets management argue it is getting ahead of a new set of threats as enterprise AI deployments spread. The market approved of both the guidance and the acquisition on the same morning.
The move spread to peers. CrowdStrike rose 6.1% to $251.50 premarket, adding to a 7.95% gain on Wednesday. Over the past 12 months it is up 93.23%, and 23.49% over the past three months. Everpure gained 7.15% to $107.94 before the open, Coherent and Bloom Energy were also among the S&P 500’s top premarket gainers, and top moves across the index approached 10%. Cybersecurity and retail strength were the main props for the Nasdaq during Wednesday’s 0.42% gain, and the group again absorbed some of Thursday’s chip-driven fade.
Security software is holding up while hardware gets sold because of the revenue model. Palo Alto and CrowdStrike sell recurring subscriptions whose growth depends on enterprise AI adoption, not on any one lab’s capital spending, so a CEO crisis at Nvidia or a China report on AMD doesn’t affect their order books. Investors who want AI exposure without accelerator supply-chain risk are rotating into recurring-revenue software. JPMorgan’s disclosure Thursday that some third-party vendors were targeted in a cyberattack, with no service disruption reported, was a timely reminder of the demand these companies serve.
UnitedHealth’s 18% Five-Day Slide Drags the Dow
The Dow’s 500-point loss is mostly a healthcare story, and UnitedHealth is at the center of it. The stock fell another 5% on Thursday morning, putting it on track for an 18% decline over five sessions. On Wednesday it dropped $39.77, or 10.21%, to close at $349.91 on 17.39 million shares, and that move alone took 236 points off the Dow. A further 5% cut from $349.91 puts the stock at $332 and removes more than 100 additional Dow points. UnitedHealth carries a 4.32% weight in the price-weighted average, so each dollar it moves has an outsized effect on the index.
The trigger is regulatory. On November 16, the Centers for Medicare & Medicaid Services proposed the Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH, rule. It would expand audits across Medicare, Medicaid, the Children’s Health Insurance Program and the health insurance marketplace, with the heaviest focus on Medicare Advantage, and it would let CMS claw back improper payments. Federal officials estimate the proposal would recover $90 billion over 10 years. That is an industry-wide figure, and company-level exposure is still unclear, which is why selling has hit the entire managed-care group without much distinction.
The damage extends across the sector. Humana fell 13% to $385.78 on Wednesday and CVS Health dropped 5.2% to $81.35. All seven other managed-care companies worth $2 billion or more fell in that session. UnitedHealth lost $50 billion of market value in a week, and its earnings multiple fell toward 15 times. A renewed push for Medicare for All added a second policy overhang. On Thursday the selling moved past insurers. Johnson & Johnson and Merck each fell almost 3%, which added to the Dow’s losses, and the sell-off in healthcare overall continued. Universal Health Services and HCA Healthcare were also among the sector’s laggards on the screens.
The healthcare sector fell 2.2% on Wednesday, the second-worst S&P 500 group behind energy’s 3.5% drop. Healthcare is still up 18.5% year to date, far ahead of the S&P 500’s 7.9% gain, which makes it the most crowded defensive group in the market and leaves plenty of gains to sell. Until CMS publishes company-level estimates or the comment period changes the rule, insurers will trade on worst-case assumptions, and the Dow will havetrouble holding 50,000 with its heaviest healthcare weight falling 5% to 10% a day.
Read More
-
Yen Stalls at 160 Despite a 3% JGB and Tokyo Core CPI at 2.0% — Intervention Sits at 164, Friday's Payrolls Decide
02.09.2026 · TradingNEWS ArchiveEnergy
-
VOO ETF Holds $673.90 After 4 Straight Losses; Nvidia’s Beat and a $668 Floor Point to $698
18.11.2026 · TradingNEWS ArchiveStocks
-
Bitcoin Holds $63K Floor as $2.9B ETF Exodus Meets Fed Hike Bets; $68K Target in View
19.11.2026 · TradingNEWS ArchiveCrypto
-
December Natural Gas Jumps to $3.337 as Heating Outlook Hits 297 HDDs; $3.397 Break Opens $3.65
18.11.2026 · TradingNEWS ArchiveCommodities
-
USD/JPY Holds 159.32 as Ueda Backs More Hikes; Yield Gap Points to a 160.20 Retest
18.11.2026 · TradingNEWS ArchiveForex
Walmart Raises Its Outlook but the Stock Slips
Walmart’s report was the session’s main earnings release, and it shows a market more interested in rotation than in results. The company announced third-quarter results with strong revenue growth and raised its full-year outlook. Revenue came in at $188.84 billion against a $187.27 billion consensus. Adjusted earnings were 65 cents a share versus 64 cents expected. U.S. same-store sales rose 2.9% from a year earlier, in line with forecasts, and e-commerce sales jumped 17%, helped by store-fulfilled pickup and delivery. Despite all that, the stock fell 1.40% in early trading.
The guidance revision was broad. Walmart now expects fiscal 2027 net sales to grow 4.9% to 5.2% in constant currency, up from 4.0% to 5.0%. Adjusted operating income is now expected to grow 8.0% to 8.6%, up from 7.0% to 8.5%. Adjusted EPS guidance rose to $2.84 to $2.89 from $2.80 to $2.87. Compared with the original February outlook of 3.5% to 4.5% sales growth and 6.0% to 8.0% operating income growth, the company has raised both lines three quarters in a row. Quarterly revenue went from $177.8 billion a year ago to $188.8 billion now, and gross margin expanded 28 basis points from the prior year.
Leadership highlighted a cost pressure that the broader market should pay attention to. CEO John Furner said Walmart is working to hold prices down despite surging diesel costs, a direct result of crude trading above $80 while the U.S.-Israeli war with Iran continues. Fuel is the biggest variable cost in a delivery network that now carries 17% e-commerce growth. The timing of Flipkart’s Big Billion Days also shifted between the third and fourth quarters, which distorted year-over-year international comparisons. Management pointed to market-share gains across categories and income tiers, plus new growth from membership and agentic shopping.
The sell-the-news reaction comes from where the stock stood going in. Over the past week, investors have bid up consumer staples such as Coca-Cola while selling anything tied to the data-center buildout, so the defensive trade was crowded before Walmart reported. With an in-line comp and a modest beat, there wasn’t enough upside to bring in new buyers, and the 1.40% drop was enough for Walmart to add to the Dow’s losses.
Jobless Claims at 203,000 and a Philadelphia Fed Collapse to 6.3
The morning’s economic releases pointed toward slowing growth, which is a problem for a Federal Reserve that is still leaning toward a rate hike. Initial jobless claims rose 1,000 to a seasonally adjusted 203,000 for the week ended November 14, above the 197,000 consensus. The prior week was revised up to 202,000 from 200,000. The four-week average rose 2,000 to 197,750. Claims had stayed at or below 200,000 since mid-September, so this is the second straight reading above that level. Continuing claims rose 70,000 to 1.763 million, meaning laid-off workers are taking longer to find new jobs.
The bigger miss came from the factory sector. The Philadelphia Fed business outlook index fell to 6.3 from 20.9, against an expected 23.2, its lowest reading since May. The 16.9-point miss against consensus is one of the largest of the year. New orders dropped to minus 0.4, so incoming demand in the region contracted outright. The prices-paid component rose to 58.2, putting stagflation into one report: output and orders are slowing while input costs keep climbing. The Kansas City Fed manufacturing index, last at 11, completes Thursday’s regional data.
Retail sales slowed from September but edged up in October, so the consumer is still spending, though at a slower pace than in the third quarter. The labor market has settled into a pattern of moderate hiring and few layoffs. Entry-level hiring is still hard, but conditions are better than a year ago. This claims reading came during the survey week for November’s nonfarm payrolls report, and because of the revised Labor Department schedule, the Fed will not get October or November payroll data before its December 9 meeting. The next claims report comes a day early, on Wednesday, November 25, because of Thanksgiving.
The data frames the Fed’s choice. A 203,000 claims print is still historically low and doesn’t argue for easing. A Philadelphia Fed reading of 6.3 with prices paid at 58.2 is the combination that makes a hike harder to justify and harder to skip. Equities read the morning as negative on both counts: growth is slowing enough to hurt earnings estimates, but not enough to take the December hike off the table. Small caps, which rely most on domestic demand and floating-rate debt, got the worst of it, with the Russell 2000 down 0.78%.
A 5.08% 10-Year and a December Hike Priced at 95%
Rates are the main constraint on this market, and they did not ease on Thursday. The 10-year Treasury yield rose almost 2 basis points to 5.085%, after a fourth straight decline brought it to 5.064% on Wednesday. The 2-year yield rose more than 2 basis points to 4.826%, and the 30-year bond rose more than 1 basis point to 5.426%. A 10-year above 5% has held for weeks. Over one stretch the 2-year jumped 33 basis points to 4.84% and the 10-year 28 basis points to 5.14%, a bear-flattening move driven by hot inflation data.
Wednesday’s minutes from the October 27–28 FOMC meeting kept a hike in play. The Fed held the target range at 3.75% to 4.00% on a 10–2 vote. The minutes showed policymakers confident about a rate increase in December but wanting more data first. “Many” participants pointed to signs of modest tightening in the labor market, while the committee broadly expected conditions to stay stable in the near term and saw labor-market risks as balanced. Governor Christopher Waller called for aggressive action against inflation and said it has proved more persistent than he expected. Before the minutes were released, rate traders priced a 95% chance of a quarter-point hike at the December 9 meeting.
Equity valuations carry the cost of that path. A 5.08% risk-free rate sets a high hurdle for the S&P 500’s long-duration growth weights, which explains why the market can’t hold an AI rally even with a record IPO on the board. Each basis point on the 10-year comes straight out of the multiple investors will pay for Nvidia’s forward earnings or Anthropic’s 2028 revenue. A stronger dollar after the hawkish minutes also tightens financial conditions further and pressures multinational earnings converted from foreign currencies.
The market’s main question now is whether lower long-end yields or the Fed’s hike guidance wins out. The four-session decline in the 10-year through Wednesday was the one tailwind behind the overnight futures rally. Its reversal on Thursday morning, even by only 2 basis points, came at the same time stocks turned lower. Rate expectations will reset with a full slate of Fed speeches through the rest of the session, and with no payroll data due before the decision, every speech carries extra weight. Equities need the 10-year back below 5%, and the 5.064% low of the past week is the first level to watch.
Oil at $83, Gold at $3,683, Bitcoin at $63,000: The Cross-Asset Tape
Commodity prices are adding to the inflation problem the Fed is trying to manage. December WTI was up $1.12, or 1.36%, at $83.43 by late morning and touched $83.68 midmorning. Brent rose to $92.40. That spread over WTI, just under $9, stays wide because of Middle East shipping risk. The bounce follows a sharp drop. WTI fell 3.2% on Wednesday to its lowest close since August 26 after U.S. crude inventories rose 3.4 million barrels, far more than forecast, and both benchmarks are down 15% this month after Washington delayed new military action against Iran. Brent traded at $110.17 a month ago and is still $29.50 above its level a year ago.
Energy stocks are not following crude higher. The energy sector fell 3.5% on Wednesday, the worst of the 11 S&P 500 groups, and the selling continued in refiners on Thursday. Valero, Marathon Petroleum, Phillips 66 and PBF Energy have been the group’s laggards as falling crack spreads and the month’s 15% decline in crude wiped out the margin story behind their earlier gains. The XLE energy fund fell 3.3% on Wednesday. Thursday’s 1.36% crude bounce has not brought buyers back, which shows energy positioning is being cut and not added to.
Gold is moving opposite to what the war headlines would suggest. The metal fell $58.80, or 1.57%, to $3,683.10, after a 1.09% drop to $3,701.20 at midmorning. That is a loss of more than $100 an ounce in two sessions, as a 5.08% 10-year yield and the firmer dollar after the minutes raise the cost of holding a non-yielding asset. Bitcoin rose $339.77, or 0.54%, to $63,029.40 after a midmorning print near $63,285, and recovered toward $64,000 overnight. Crypto-linked miners such as Riot Platforms, Cipher Digital and TeraWulf have been among the market’s most active names as traders link hashrate capacity to the AI data-center trade.
The cross-asset picture is consistent. Real yields above 5% are pressuring gold, crude is stuck between war risk and supply surplus, and the VIX at 25.49 shows equity hedging demand rising. No major asset is giving a clear risk-on signal. Bitcoin’s 0.54% gain is the closest thing to one, and at $63,000 the token is still far below its peak.
Narrow Leadership, Key S&P 500 Levels and the Session Verdict
Breadth is the weakest part of the market. By late morning technology was the only S&P 500 group still positive, with healthcare, energy, financials and industrials all lower. In Wednesday’s close, six of 11 sectors fell, the Dow had 20 of its 30 members lower, and the Nasdaq gained only because AMD, Broadcom and Amazon offset Nvidia’s 2.9% drop. On Thursday the setup is narrower still. The Nasdaq’s gain rests on a few mega-caps such as Microsoft at 2.3% and Nvidia’s 1.5% bounce, while AMD’s 8% drop and the semiconductor fade erased most of the group’s support. When only one sector stays green on a day with a record IPO, the market’s footing is weak.
The S&P 500 levels are clearly defined. The Wednesday close at 7,323.63 is the first line, and the index has been below it for most of the morning at 7,306.20. A close under it would make it six straight losses, the longest streak of the year. Immediate support is at 7,300, and a decisive break below opens a test of 7,250, a further 0.8% drop from the late-morning level. The index has lost 4.1% over the past month, and the 7,700 area from mid-October is where the decline started. Resistance comes from the morning’s peak above 7,415. An S&P 500 that reclaims 7,400 and closes there would undo the morning fade and open the next target at 7,500, the midpoint of the month-long drawdown. The 7,500 level is the upside objective if the 10-year drops back below 5% and the rotation out of AI hardware stops.
The Dow levels are 50,000 and Wednesday’s 50,198.17 close. The index needs both to stop the healthcare-led slide, and with UnitedHealth down 5% intraday, a recovery above 50,000 before the close is unlikely. The Nasdaq has to hold 24,429.89, its prior close, to keep a positive day. At 24,495.14 its cushion was only 65 points late in the morning, and Anthropic’s first trade is the swing factor for the afternoon. A first print at the top of the $105 to $110 indication range could lift AI proxies again, while a weak first trade would expose the Nasdaq’s thin gain.
The session verdict is bearish with narrow tech support. The S&P 500 is heading for a sixth straight loss, the Dow has lost 50,000, small caps are lagging, the VIX is rising and only one sector is positive, while a record $81.34 billion IPO is being used as liquidity to sell semiconductors. The bid in AI is real but limited to a small group, rates at 5.08% keep a ceiling on valuations, and the healthcare sell-off has no regulatory floor yet. Until the S&P 500 closes back above 7,400 with the 10-year under 5%, rallies are better treated as selling opportunities than as the start of a recovery, and the market’s next real catalyst is the Fed’s December 9 decision.